Navigation Links
Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President
Date:12/1/2009

PLEASANTON, Calif., Dec. 1 /PRNewswire/ -- The new position of Executive Vice President, Commercial Affairs at Microchip Biotechnologies, Inc. has been taken up by Howard Goldstein, a biotech lab systems executive with more than 30 years of experience creating and managing life science product organizations. Mr. Goldstein will direct Microchip Biotechnologies' marketing, business development, sales and customer service operations as the company makes the transition from product development to full commercial operations.

"Howard adds directly relevant strategic, operational, and commercial experience to our executive profile," said Stevan Jovanovich, President/CEO of Microchip Biotechnologies. "His leadership and expertise will be keys to the realization of our commercial growth objectives."

Prior to joining Microchip Biotechnologies, Mr. Goldstein first served as Chief Executive Officer and then Chief Commercial Officer of Arcxis Biotechnologies, and was Managing Partner of Practical Marketing and Sales, a biotech business consultancy. He has been responsible for building and directing marketing, engineering, and sales teams that have created more than 10 key product categories in the research marketplace. Mr. Goldstein received his MBA degree in Organizational Development from Temple University, Philadelphia, PA and an M.Sc. degree in Biochemistry from the University of Dayton, Dayton OH.

About Microchip Biotechnologies, Inc.

Microchip Biotechnologies, Inc. (MBI), headquartered in Pleasanton, CA is a venture-backed, privately held company that produces automated sample processing systems for life sciences, applied sciences, and healthcare diagnostics markets. The company's products are based on the Apollo fluidics technology platform, which integrates advanced fluidics and analytical capabilities to produce automated sample-to-answer systems for DNA and RNA sequencing, DNA-based forensics and human identity (HID) testing, biodefense, and molecular diagnostics applications. The company's first product, the Apollo 100 System, automates sample processing for Sanger cycle sequencing and dramatically reduces process requirements for expensive sequencing reagents. For additional information about MBI, visit http://www.microchipbiotech.com.


Contact: Howard D. Goldstein
Microchip Biotechnologies Inc.
5720 Stoneridge Drive, Suite 300
Pleasanton, CA 94568
(925) 701-3481
howard.goldstein@microchipbiotech.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE Microchip Biotechnologies, Inc.


'/>"/>
SOURCE Microchip Biotechnologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Scott Glenn Joins Exagen Diagnostics as Chairman and CEO
2. PFC Pharma Joins DATATRAKs CRO Connect Program
3. William Cork Joins Fenwal as Chief Technology Officer
4. Jeffrey Trotter Joins Pharmanet Development Group as Executive Vice President, Phase IV Development
5. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
6. American Lung Association of California Joins Sheriffs Department to Support Influenza Vaccination In Sacramento
7. Marsha Fanucci Joins Ironwood Board of Directors
8. Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development
9. The Medco Foundation Joins With the Entertainment Industry Foundation to Give Health a Hand to Communities in Need
10. Dilon Diagnostics Joins Forces With Philips for Womens Health Solutions
11. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
Breaking Medicine News(10 mins):